Patients Stopping Weight-Loss Injections Regain Pounds Far More Rapidly Than Those on Conventional Diets

A recent study indicates that individuals who discontinue blockbuster GLP-1 drugs like Mounjaro or Wegovy tend to recover lost weight far faster than those who stop conventional diet and exercise programs.

Published data in a major health publication demonstrates that while obese people frequently drop substantial amounts of their total mass while using the jabs, the weight comes back at an estimated rate of 0.8 kg per month upon discontinuation.

"Users buying these drugs need to be aware of the potential of rapid rebound weight gain when the treatment ends," stated researcher Dr. Susan Jebb.

Such speed of regain means a reversion to pre-treatment mass in about 18 months.

Analyzing Treatments

The analysis, which looked at 37 of trials involving thousands of patients, compared the outcomes of GLP-1 agonists with conventional dieting.

Researchers point out that people who shed pounds through dieting typically experience a less rapid weight regain—approximately 100 grams monthly—post-intervention.

Explaining the Quick Rebound

Nutrition scientists suggest the way of the injections is key to understanding the accelerated regain.

The injections copy a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.

"Artificially providing the hormone concentrations several times higher than normal may cause the system to produce less of its endogenous hormone, and could lessen responsiveness to its actions," said Dr. Adam Collins, a nutrition specialist.

"Withdrawal of this medication leads to appetite is no longer kept in check, making excessive eating a significant risk."

An Ongoing Condition?

Health authorities recommend the injections for individuals with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.

Many experts argue that, due to the significant potential of relapse, the treatment is often ongoing.

This perspective is echoed by pharmaceutical companies, who state that the findings "underscore the persistent character of obesity," akin to managing diseases like diabetes.

User Experiences

People who have come off the jabs explain a powerful resurgence of cravings.

"It felt as if something flipping and you're instantly extremely hungry," described an individual.

This difficulty is compounded if users have not adopted sustainable lifestyle or habit changes during therapy.

Significant Interest

Survey data suggest that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with demand continuing to grow.

• Use is greater among females compared to males.
• The middle-aged demographic shows the highest usage rates.
• Many obtain the medications through private prescriptions rather than the NHS.

Finally, clinicians stress that while these medications are effective agents for shedding pounds, they are not a standalone cure and lasting health benefits likely depends on ongoing lifestyle changes.